These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8238433)

  • 1. Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation.
    Khandelwal SR; Randad RS; Lin PS; Meng H; Pittman RN; Kontos HA; Choi SC; Abraham DJ; Schmidt-Ullrich R
    Am J Physiol; 1993 Oct; 265(4 Pt 2):H1450-3. PubMed ID: 8238433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dose-dependent effect of RSR13, a synthetic allosteric modifier of hemoglobin, on physiological parameters and brain tissue oxygenation in rats.
    Grinberg OY; Miyake M; Hou H; Steffen RP; Swartz HM
    Adv Exp Med Biol; 2003; 530():287-96. PubMed ID: 14562725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RSR13, a synthetic modifier of hemoglobin-oxygen affinity, enhances the recovery of stunned myocardium in anesthetized dogs.
    Pagel PS; Hettrick DA; Montgomery MW; Kersten JR; Steffen RP; Warltier DC
    J Pharmacol Exp Ther; 1998 Apr; 285(1):1-8. PubMed ID: 9535987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of RSR13, a synthetic allosteric modifier of hemoglobin, on brain tissue pO2 (measured by EPR oximetry) following severe hemorrhagic shock in rats.
    Miyake M; Grinberg OY; Hou H; Steffen RP; Elkadi H; Swartz HM
    Adv Exp Med Biol; 2003; 530():319-29. PubMed ID: 14562728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of RSR13 on microvascular Po
    Watanabe A; Poole DC; Kano Y
    J Appl Physiol (1985); 2017 Oct; 123(4):764-772. PubMed ID: 28620055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice.
    Khandelwal SR; Kavanagh BD; Lin PS; Truong QT; Lu J; Abraham DJ; Schmidt-Ullrich RK
    Br J Cancer; 1999 Feb; 79(5-6):814-20. PubMed ID: 10070874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13.
    Amorino GP; Lee H; Holburn GE; Paschal CB; Hercules SK; Shyr Y; Steffen RP; Choy H
    Radiat Res; 2001 Sep; 156(3):294-300. PubMed ID: 11500138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study.
    Hou H; Khan N; O'Hara JA; Grinberg OY; Dunn JF; Abajian MA; Wilmot CM; Makki M; Demidenko E; Lu S; Steffen RP; Swartz HM
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):834-43. PubMed ID: 15183487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an allosteric modifier of hemoglobin, RSR-4, on oxygen affinity and oxygen saturation of hemoglobin in rabbits.
    Uchida K; Reilly MP; Abraham DJ; Asakura T
    Jpn J Physiol; 1998 Dec; 48(6):439-44. PubMed ID: 10021497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modification of oxygen delivery by hemoglobin.
    Wahr JA; Gerber M; Venitz J; Baliga N
    Anesth Analg; 2001 Mar; 92(3):615-20. PubMed ID: 11226087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raising P50 increases tissue PO2 in canine skeletal muscle but does not affect critical O2 extraction ratio.
    Curtis SE; Walker TA; Bradley WE; Cain SM
    J Appl Physiol (1985); 1997 Nov; 83(5):1681-9. PubMed ID: 9375339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric modification of hemoglobin by RSR13 as a therapeutic strategy.
    Steffen RP; Liard JF; Gerber MJ; Hoffman SJ
    Adv Exp Med Biol; 2003; 530():249-59. PubMed ID: 14562722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of FI(O(2)) on hemodynamic responses and O(2) transport during RSR13-induced reduction in P(50).
    Eichelbrönner O; Sielenkämper A; D'Almeida M; Ellis CG; Sibbald WJ; Chin-Yee IH
    Am J Physiol; 1999 Jul; 277(1):H290-8. PubMed ID: 10409208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing P(50) does not improve DO(2CRIT) or systemic VO(2) in severe anemia.
    Eichelbrönner O; D'Almeida M; Sielenkämper A; Sibbald WJ; Chin-Yee IH
    Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H92-101. PubMed ID: 12063279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I trial to determine the safety, pharmacodynamics, and pharmacokinetics of RSR13, a novel radioenhancer, in newly diagnosed glioblastoma multiforme.
    Kleinberg L; Grossman SA; Piantadosi S; Pearlman J; Engelhard H; Lesser G; Ruffer J; Gerber M
    J Clin Oncol; 1999 Aug; 17(8):2593-603. PubMed ID: 10561327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of canine myocardial high-energy phosphates during low-flow ischemia with modification of hemoglobin-oxygen affinity.
    Weiss RG; Mejia MA; Kass DA; DiPaula AF; Becker LC; Gerstenblith G; Chacko VP
    J Clin Invest; 1999 Mar; 103(5):739-46. PubMed ID: 10074492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of enhanced oxygen release from hemoglobin by RSR13 in an acute renal failure model.
    Burke TJ; Malhotra D; Shapiro JI
    Kidney Int; 2001 Oct; 60(4):1407-14. PubMed ID: 11576354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RSR13, a synthetic allosteric modifier of hemoglobin, improves myocardial recovery following hypothermic cardiopulmonary bypass.
    Kilgore KS; Shwartz CF; Gallagher MA; Steffen RP; Mosca RS; Bolling SF
    Circulation; 1999 Nov; 100(19 Suppl):II351-6. PubMed ID: 10567328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right-shifting the oxyhemoglobin dissociation curve with RSR13: effects on high-energy phosphates and myocardial recovery after low-flow ischemia.
    Woods JA; Storey CJ; Babcock EE; Malloy CR
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):359-63. PubMed ID: 9514179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-affinity hemoglobin increases tissue PO2 and decreases arteriolar diameter and flow in the rat cremaster muscle.
    Kunert MP; Liard JF; Abraham DJ; Lombard JH
    Microvasc Res; 1996 Jul; 52(1):58-68. PubMed ID: 8812756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.